NO803516L - Fremgangsmaate ved fremstilling av acylderivater - Google Patents

Fremgangsmaate ved fremstilling av acylderivater

Info

Publication number
NO803516L
NO803516L NO803516A NO803516A NO803516L NO 803516 L NO803516 L NO 803516L NO 803516 A NO803516 A NO 803516A NO 803516 A NO803516 A NO 803516A NO 803516 L NO803516 L NO 803516L
Authority
NO
Norway
Prior art keywords
salt
acyl derivatives
see diagramm
procedure
preparation
Prior art date
Application number
NO803516A
Other languages
English (en)
Other versions
NO166229C (no
NO166229B (no
Inventor
Marc Montavon
Roland Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO803516L publication Critical patent/NO803516L/no
Priority to NO81812083A priority Critical patent/NO166228C/no
Publication of NO166229B publication Critical patent/NO166229B/no
Publication of NO166229C publication Critical patent/NO166229C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Table Devices Or Equipment (AREA)
  • Laminated Bodies (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
NO803516A 1979-11-21 1980-11-20 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cephalosporinderivater. NO166229C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO81812083A NO166228C (no) 1979-11-21 1981-06-18 Halogenerte cephalosporinderivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1038479 1979-11-21

Publications (3)

Publication Number Publication Date
NO803516L true NO803516L (no) 1981-05-22
NO166229B NO166229B (no) 1991-03-11
NO166229C NO166229C (no) 1991-06-19

Family

ID=4362652

Family Applications (2)

Application Number Title Priority Date Filing Date
NO803516A NO166229C (no) 1979-11-21 1980-11-20 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cephalosporinderivater.
NO81812083A NO166228C (no) 1979-11-21 1981-06-18 Halogenerte cephalosporinderivater.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO81812083A NO166228C (no) 1979-11-21 1981-06-18 Halogenerte cephalosporinderivater.

Country Status (21)

Country Link
EP (1) EP0030294B1 (no)
JP (2) JPS5692894A (no)
KR (1) KR860000852B1 (no)
AT (1) ATE8896T1 (no)
AU (1) AU533088B2 (no)
CA (1) CA1146165A (no)
DE (1) DE3068905D1 (no)
DK (1) DK166728B1 (no)
ES (2) ES8200694A1 (no)
FI (2) FI67385C (no)
GR (1) GR71879B (no)
HU (1) HU184941B (no)
IE (1) IE50516B1 (no)
IL (1) IL61486A (no)
NO (2) NO166229C (no)
NZ (1) NZ195547A (no)
PH (2) PH17359A (no)
PT (1) PT72084B (no)
SI (1) SI8012952A8 (no)
YU (1) YU42364B (no)
ZA (1) ZA807099B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830051B2 (ja) * 1986-05-21 1996-03-27 武田薬品工業株式会社 ４−ハロゲノ−２−置換オキシイミノ−３−オキソ酪酸のエステルまたはアミドの製造法
JP2595605B2 (ja) * 1988-01-18 1997-04-02 武田薬品工業株式会社 ２−置換オキシイミノ−３−オキソ酪酸の製造法
AT398764B (de) * 1992-01-28 1995-01-25 Lek Tovarna Farmacevtskih Verfahren zur herstellung von ceftriaxondinatrium-salzhemiheptahydrat
AT399877B (de) * 1992-02-20 1995-08-25 Biochemie Gmbh Neues verfahren zur herstellung von ceftriaxon
AT411598B (de) * 1999-04-29 2004-03-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen
AT408225B (de) * 1999-04-29 2001-09-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen
EP1399429A1 (en) * 2001-06-14 2004-03-24 Orchid Chemicals and Pharmaceuticals Ltd 1,3,4-oxadiazol-2-yl thioesters and their use for acylating 7-aminocephalosporins
IN192139B (no) 2001-11-26 2004-02-21 Lupin Ltd
WO2003089406A1 (en) * 2002-04-19 2003-10-30 Orchid Chemicals And Pharmaceuticals Limited A process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
US6919449B2 (en) 2002-04-19 2005-07-19 Orchid Chemicals And Pharmaceuticals Limited Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
US6800756B2 (en) 2002-05-03 2004-10-05 Orchid Chemicals And Pharmaceuticals, Ltd. Method for the preparation of ceftiofur sodium and its intermediates
WO2004083216A1 (en) * 2003-03-20 2004-09-30 Orchid Chemicals & Pharmaceuticals Ltd A process for the preparation of cephalosporins
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
ES2348299T3 (es) 2003-04-16 2010-12-02 Sandoz Ag Procedimientos para la preparación de cefepime.
WO2004111059A1 (en) * 2003-06-19 2004-12-23 Orchid Chemicals & Pharmaceuticals Ltd A process for the preparation of a cephalosporin antibiotic
WO2005019227A1 (en) 2003-08-22 2005-03-03 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cephalosporin antibiotic
US20050059820A1 (en) * 2003-09-17 2005-03-17 Debashish Datta Method for manufacture of ceftriaxone sodium
WO2005040175A2 (en) * 2003-10-22 2005-05-06 Ranbaxy Laboratories Limited Process for the preparation of cephem carboxylic acids
US20050119244A1 (en) 2003-12-02 2005-06-02 Acs Dobfar S.P.A. Process for preparing cephalosporins with salified intermediate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200745A (en) * 1977-12-20 1980-04-29 Eli Lilly And Company 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins
JPS5498795A (en) * 1978-01-13 1979-08-03 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles

Also Published As

Publication number Publication date
ATE8896T1 (de) 1984-08-15
GR71879B (no) 1983-08-03
PH18468A (en) 1985-07-18
ES496994A0 (es) 1981-11-16
FI67385C (fi) 1985-03-11
ES8204997A1 (es) 1982-06-01
IL61486A (en) 1984-04-30
DE3068905D1 (en) 1984-09-13
PH17359A (en) 1984-08-01
NO166229C (no) 1991-06-19
NZ195547A (en) 1983-05-10
FI793768A (fi) 1981-05-22
IE50516B1 (en) 1986-04-30
NO812083L (no) 1981-12-22
DK166728B1 (da) 1993-07-05
FI67385B (fi) 1984-11-30
DK496380A (da) 1981-05-22
AU6443880A (en) 1981-05-28
IL61486A0 (en) 1980-12-31
IE802408L (en) 1981-05-21
JPH0248559B2 (no) 1990-10-25
NO166228B (no) 1991-03-11
PT72084A (en) 1980-12-01
EP0030294A2 (de) 1981-06-17
AU533088B2 (en) 1983-10-27
NO166229B (no) 1991-03-11
ES503583A0 (es) 1982-06-01
JPS6145995B2 (no) 1986-10-11
FI842614A0 (fi) 1984-06-28
NO166228C (no) 1991-06-19
JPS5692894A (en) 1981-07-27
FI842614A (fi) 1984-06-28
SI8012952A8 (en) 1997-06-30
HU184941B (en) 1984-11-28
EP0030294A3 (en) 1981-12-09
JPS61143392A (ja) 1986-07-01
KR860000852B1 (ko) 1986-07-09
FI71563C (fi) 1987-01-19
CA1146165A (en) 1983-05-10
KR830004315A (ko) 1983-07-09
PT72084B (en) 1982-07-30
ES8200694A1 (es) 1981-11-16
ZA807099B (en) 1981-11-25
EP0030294B1 (de) 1984-08-08
YU295280A (en) 1983-06-30
FI71563B (fi) 1986-10-10
YU42364B (en) 1988-08-31

Similar Documents

Publication Publication Date Title
NO803516L (no) Fremgangsmaate ved fremstilling av acylderivater
NZ194303A (en) 2- phenylimidazo (4,5-b) pyridines
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
SE7602144L (sv) Kvaternera imidazoliumforeningar
JPS5616477A (en) Triazolyllalkene derivative* its manufacture and its use as bactericide
YU310580A (en) Process for obtaining new benzothiazole derivatives
EP0298752A3 (en) Mercapto-substituted pyridine compounds and process for preparing the same
SE7413858L (no)
JPS57156440A (en) Novel derivatives of 4-methyl-3-formylpentanoic acid, manufacture and use for manufacturing cyclic derivatives
GB1427066A (en) Fused ring indole derivatives
JPS54160393A (en) Cephem compound having halogenoalkyl group at the 3-position
JPS5547666A (en) Thiazolidine carboxylic acid derivative
GB1413794A (en) Chemical process for the manufacture of alkanolamine derivatives